HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

879.551

+3.6350.42%

Number of Gainers:8

Number of Losers:7

Number of Flat:2

PE:- -

High:885.329

Open:878.139

Low:871.523

Close:875.916

Volume:128.72M

Turnover:901.05M

Market Cap:594.75B

Float Cap:492.24B

Loading ...

Hong Kong Stocks in Focus: SBP Group Jumps Nearly 3% on Double New Drug Approval Submissions

Sino Biopharmaceutical Says China's CDE Accepts NDA for Tqh2722 Injection

Hong Kong Market Open: Hang Seng Index Rises 0.50% as Optics Stocks Rally, CATL Slides Over 2%

Chinese Regulator Accepts NDA for Sino Biopharm's Breast Cancer Drug

MT Newswires Live

China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval

Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection

THOMSON REUTERS

China Traditional Chinese Medicine Says Subsidiaries Enter Contracts

China Traditional Chinese Medicine - Pharmengin Contracted for Shandong Yifang Renovation Project at Rmb10.6 Mln, Others

THOMSON REUTERS

China Traditional Chinese Medicine Holdings - Subsidiaries Enter Contracts on Sept 15, 2026

THOMSON REUTERS

ALI HEALTH Awards 7.67 Million Restricted Share Units Under Incentive Scheme

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

MT Newswires Live

Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA

CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS

GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15

Fosun Pharma Spends HK$22.07 Million on Share Buyback on September 15

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Alibaba Health Information Technology Stock Slides 2.5% in Hong Kong

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":879.5508,"timestamp":1789537784569,"preClose":875.9157,"halted":0,"volume":128723893,"delay":0,"changeRate":0.00415,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":3.635071,"latestTime":"09-16 13:49:45","open":878.13885,"high":885.32947,"low":871.5229,"amount":901046995,"amplitude":0.015762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789546200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":1.316272,"peRate":17.057675,"turnoverRate":0.001763,"increases":8,"decrements":7,"flats":2,"marketCap":594745001792,"floatMarketCap":492239791936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":885.32947,"amplitude":0.015762,"preClose":875.9157,"low":871.5229,"pbRate":"1.316272","latestPrice":879.5508,"volume":128723893,"delay":0,"open":878.13885,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":912.778,"twentyDayClose":905.419,"sixtyDayClose":815.098,"secType":"PLATE","market":"HK","turnoverRate":0.001763,"peRate":17.057675,"marketCap":594745001792,"floatMarketCap":492239791936,"timestamp":1789537784569,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":8,"down":7,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1124637376","title":"Hong Kong Stocks in Focus: SBP Group Jumps Nearly 3% on Double New Drug Approval Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=1124637376","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124637376?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:36","pubTimestamp":1789526174,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) advanced nearly 3% in Thursday's trading session, with the stock last up 1.94% at HK$5.525, registering a turnover of HK$104 million.On Monday, the company announced that...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","VXUS","BK1589","BK4585","IE00BZ08YT58.USD","01177","KCAI","IPOS","BK1521","BK1191","IE00BZ08YS42.EUR","HK0000165453.HKD","BK4588","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676521","title":"Sino Biopharmaceutical Says China's CDE Accepts NDA for Tqh2722 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676521","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676521?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:53","pubTimestamp":1789523606,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 InjectionSept 16 (Reuters)-Sino Biopharmaceutical Limited1177.HK:CHINA'S CDE ACCEPTS NEW DRUG APPLICATION FOR TQH2722 INJECTION 'IL-4R MONOCLONAL ANTIBODY'Further company coverage:1177.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4570V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YR35.GBP","BK1521","IE00BZ08YT58.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","BK1191","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102350053","title":"Hong Kong Market Open: Hang Seng Index Rises 0.50% as Optics Stocks Rally, CATL Slides Over 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102350053","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102350053?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:53","pubTimestamp":1789523589,"startTime":"0","endTime":"0","summary":"Hong Kong stocks opened higher on September 16, with the Hang Seng Index climbing 0.50% to 24,789.91 points. The Hang Seng Tech Index advanced 0.47% to 4,311.70 points, while the Hang Seng China...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823040885.USD","LU0880133367.SGD","LU0417516902.SGD","IE0003895053.USD","LU0359202008.SGD","LU1868837722.USD","LU0672654166.SGD","HK0000288784.HKD","LU1961090484.USD","LU0588545490.SGD","LU0640798160.USD","LU0651947912.USD","LU2133065610.SGD","LU0823397285.USD","BK1221","LU2317271919.USD","LU2097828714.EUR","LU1023057109.AUD","BK1577","LU0326948709.USD","LU1051768304.USD","SG9999001093.SGD","03419","07300","LU0329678337.USD","LU1917777945.USD","LU1813983027.USD","LU2462611646.USD","SGXZ51526630.SGD","BK1179","IE00BQXX3C00.GBP","BK1571","BK1517","LU1166156734.SGD","LU2125910849.SGD","LU1226287875.USD","IE0001KFT4U8.USD","LU1785774172.SGD","LU2294711473.HKD","LU0385154629.USD","03067","CLPHY","LU0320764755.SGD","LU0589944569.HKD","SG9999001226.SGD","BK1506","MIUmain","LU0516423091.SGD","IE00BQXX3F31.USD","LU2008162690.USD","BK1523","SG9999018865.SGD","LU0128525689.USD","LU1725190679.HKD","LU0348816934.USD","LU1152091754.HKD","LU1769817096.USD","LU2023250504.SGD","07500","09067","LU0048388663.USD","LU0096374516.USD","LU1868838027.USD","LU0972618739.USD","GAMR","LU2362541273.HKD","BIDD","LU1993786604.SGD","LU0456842615.SGD","SGXZ31699556.SGD","LU0043850808.USD","LU0823397103.USD","LU0310800965.SGD","LU0878004406.USD","LU1497734951.SGD","02828","LU0700851271.USD","LU0261950983.USD","LU1115378108.SGD","LU0261947096.USD","LU0594300419.USD","LU0856984785.SGD","LU1282648689.USD","BK1526","LU1328615791.USD","LU0128522157.USD","LU0192582467.USD","LU0531971595.HKD","LU1251922891.USD","BK1602","LU0455707207.USD","LU1044875133.USD","LU0054237671.USD","LU0501845795.SGD","BKF","LU1048588211.SGD","SG9999017495.SGD","BK1516","LU1883866441.USD","IE0008369823.USD","SG9999015952.SGD","HK0000306701.USD","IE00B0JY6N72.USD","BK1515","LU2148510915.USD","LU0264606111.USD","LU0173614495.USD","HSCEI","LU1868837565.USD","LU1226288253.USD","03145","LU0210533765.USD","LU0320764599.SGD","LU1439102457.SGD","03423","LU0823426308.USD","LU0259732245.USD","LU1303224171.USD","BK1170","LU2039709279.SGD","LU0738912210.USD","BK1575","01929","LU0128522744.USD","LU0080751232.USD","LU0228367735.SGD","LU1242518931.SGD","LU1568876335.HKD","03088","LU0107464264.USD","LU0531970944.HKD","BK1607","02382","LU0979878070.USD","LU0345769631.USD","LU1282649810.SGD","LU0345769128.USD","KWEB","BK1521","LU0348805143.USD","LU0051755006.USD","LU0577902454.USD","LU2237443382.USD","IE0008368411.USD","LU2125910500.SGD","LU0516422366.SGD","LU1629966141.USD","LU1733274390.USD","LU0039217434.USD","LU0229945570.USD","LU2097828474.EUR","SG9999014914.USD","SG9999015986.USD","LU1481107354.HKD","ODDS","LU0797268264.HKD","LU1196710864.SGD","LU0417516738.SGD","LU0165289439.USD","LU2237443549.SGD","02802","LU0890818403.SGD","LU1515016050.SGD","HK0001040143.USD","SG9999013353.USD","SGXZ81514606.USD","BK1142","LU1328277881.USD","HHImain","LU2045819591.USD","LU1102505929.USD","LU1718418525.SGD","BK1116","LU1951186391.HKD","LU0052750758.USD","LU1497733631.SGD","SG9999014898.SGD","LU0106959298.USD","LU0348767384.USD","LU0862451837.USD","IE00B031HW06.USD","IE00B97KM107.HKD","IE0031814852.USD","LU0163747925.USD","LU0499858438.USD","SGXZ62798434.SGD","LU2051468812.USD","EMC","LU0918141887.USD","LU0516422952.EUR","LU2449936058.SGD","LU1152091168.USD","IE00B0169N27.USD","LU0878005551.USD","LU0287142896.SGD","LU1282651121.HKD","LU0348825331.USD","LU0307460666.USD","LU1770036033.HKD","LU2152927971.USD","LU0072913022.USD","LU0049112450.USD","LU0106259558.USD","FFEM","01177","HK0000165453.HKD","IE00B3M56506.USD","LU0049853897.USD","LU2237443465.HKD","LU0611395673.USD","SG9999002562.SGD","LU1171460220.USD","LU1956131251.USD","SG9999000418.SGD","LU0244354667.USD","LU2498475776.HKD","LU0737861699.HKD","SG9999018857.SGD","BK1193","LU0329678170.USD","02319","LU0203345920.USD","LU2293587155.HKD","SG9999000327.SGD","07288","BK1224","HOKCY","IE00BF5LJ272.USD","LU0828237940.HKD","SG9999001069.SGD","SG9999006597.SGD","LU0862451753.SGD","LU0441854154.USD","LU2279701549.SGD","LU0048597586.USD","LU0117844026.USD","BK1589","BK1527","LU0235996351.USD","LU1880383440.USD","BK1608","BK1618","IE00B0169L03.USD","LU0463099449.HKD","LU1366334651.USD","LU2257852520.SGD","LU0210527791.USD","LU0143863784.USD","LU0348783662.USD","LU0873338254.USD","LU1810669033.SGD","LU0132412106.USD","XSOE","SBHMY","IE00BZ08YS42.EUR","LU2087589342.USD","LU2097828631.EUR","LU0188438112.USD","LU0702159699.USD","LU0431992006.USD","HK0000320223.HKD","LU0052756011.USD","LU0067412154.USD","LU1235295612.USD","LU1366334578.USD","LU0117841782.USD","LU0164872284.USD","LU0865486749.SGD","SOCL","SG9999007991.SGD","LU0181495838.USD","FDNI","HK0000320264.USD","LU1568876251.USD","LU0868486357.SGD","LU0169518387.USD","LU0823038988.USD","JEMA","BK1247","LU1064131003.USD","LU0164880469.USD","LU1008478684.HKD","LU0471298777.SGD","LU2237443895.HKD","80992","07588","IE00B031HY20.USD","IE00BYTNYN87.SGD","SG9999001689.USD","IE0032834883.USD","03115","IE0034224299.USD","LU0359201612.USD","LU0327786744.USD","LU0320764243.SGD","HSI","LU0348723411.USD","LU0414403682.SGD","LU1439103000.SGD","LDEM","LU0149534421.HKD","HSTECH","LU1769817179.HKD","03417","LU0577902371.SGD","LU0516423174.USD","HK0000286598.CNH","LU0314109678.HKD","BK1601","LU0251144936.SGD","LU0251143458.SGD","LU2226246903.HKD","IE00B29SXG58.USD","SG9999006514.SGD","LU0196878994.USD","LU0702159343.USD","IE00BPRC5H50.USD","LU1226288170.HKD","LU1675838814.USD","LU0683595622.HKD","LU1046422090.SGD","LU0348827113.USD","XIACY","LU1504937902.USD","LU1497733557.USD","SG9999015978.USD","LU0823413587.USD","LU0499858602.USD","TCHI","LU0572939691.SGD","BK1609","LU0348766576.USD","513600","LU1880383366.USD","LU0541501648.USD","BK1099","LU0029875118.USD","HK0000352382.USD","LU0882747503.HKD","BK1502","LU2399975544.HKD","EMCS","LU0127658192.USD","LU2362540622.SGD","IE00BGV7N243.SGD","LU0898667661.SGD","LU1044876610.USD","LU1282649141.HKD","LU0543330566.HKD","LU2242644610.SGD","SG9999014906.USD","LU0607220059.USD","LU0417516571.SGD","LU0577902298.EUR","01810","LU1282649067.USD","LU2265009873.SGD","JADE","LU0370786039.SGD","LU1064130708.USD","BK1191","LU0634319403.HKD","LU1323998911.USD","LU2237443978.SGD","LU1960683339.HKD","BK1237","LU0823426480.USD","06181","LU0054450605.USD","82800","LU1051769294.HKD","LU1226287529.USD","LU0516422440.USD","IE00BYQNZ168.SGD","LU0289960550.SGD","LU0205439572.USD","LNVGY","LU0359201885.HKD","LU0456827905.SGD","CJEWY","03037","LU0648948544.HKD","LU0823413660.USD","MIUmain","00700","BK1597","LU1814569148.SGD","IE00B12V2V27.USD","LU0328353924.USD","LU1720050803.USD","LU0348735423.USD","IE00B8HQ1Z84.USD","LU2251237488.HKD","LU0384037296.USD","LU0543330483.HKD","LU0823041008.USD","LU1642822792.SGD","HK0000914686.HKD","LU1188198961.HKD","LU0345776255.USD","SG9999002463.SGD","SG9999001846.SGD","LU0577902538.SGD","LU0449515922.USD","LU0786609619.USD","BK1531","LU1691799644.USD","LU0203347892.USD","BK1591","LU0819123356.HKD","LU0831103253.SGD","LU0456846285.SGD","BK1545","EEMX","LU1226288097.SGD","LU2663582299.SGD","LU0211977185.USD","83115","LU0449509016.USD","LU1522347837.USD","BK1096","HK0000914660.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU0345775950.USD","IE0003795394.USD","LU0072462343.USD","BK1553","LU0269904917.USD","LU0315179316.USD","LU0784639295.USD","BK1590","09088","LU1655091459.SGD","LU0572940350.SGD","BK1615","LU2279858448.HKD","LU1794554557.SGD","IE00B031J352.USD","LU1807302812.USD","BK1095","06618","00003","IE00BQXX3D17.EUR","LU0348788117.USD","02800","02837","LU0348814723.USD","HK0000306685.HKD","02833","LU1770034418.SGD","LU0231483743.USD","LU0985320562.USD","LU2106854487.HKD","LU0588545904.SGD","LU0214875030.USD","LU1974910355.USD","LU2237443622.USD","LU0708995153.HKD","LU1634259557.SGD","BK1586","LU0210526637.USD","LU1224709979.USD","LU2476274720.SGD","LU1733274473.HKD","LU0149721374.USD","LU0061477393.USD","07226","SG9999011746.SGD","SG9999004220.SGD","LU1196710351.USD","LU0594300179.USD","SG9999003461.SGD","LU1242518857.USD","LU1981816686.USD","HXXD.SI","LU0348783233.USD","LU2476274308.USD","SGXZ90724238.SGD","LU0488056044.USD","IE00B543WZ88.USD","LU0737861772.HKD","LU0561508036.HKD","SGXZ99366536.SGD","LU1808992512.USD","SG9999015945.SGD","LU0608807433.USD","00002","LU1804176565.USD","LU1831875114.USD","LU0540923850.HKD","HK0001040168.HKD","LU1048596156.SGD","LU0608807946.USD","LU1688375341.USD","IE0008368742.USD","LU0593848301.USD","IE00B8L5B284.USD","LU1102505762.USD","01024","LU0651946864.USD","LU0886674414.USD","LU0070217475.USD","CIADY","03033","LU1048484197.HKD","LU0502904849.HKD","LU0293314216.USD","LU1634259391.SGD","LU1044874839.SGD","LU0877626530.USD","LU2097828805.USD","DRGN","LU0047713382.USD","LU0541502299.USD","LU0791591158.USD","LU0106252389.USD","GB00BDT5M118.USD","LU1282651048.USD","LU0048580855.USD","SG9999001903.USD","KSTmain","LU0140636845.USD","LU1734074674.USD","LU0708995583.HKD","07552","LU0871576103.HKD","AAXJ","01478","00992","SG9999014880.SGD","LU0605514214.HKD","LU0675040207.SGD","LU2247934214.USD","LU1119993845.HKD","LU0572944931.SGD","SG9999002828.SGD","LU0315178854.USD","LU2251237306.USD","LU0011963245.USD","BK1583","SGXZ86797644.SGD","LU0164865239.USD","LU0211331839.USD","86618","07200","BK1504","IE00B067MR52.USD","LU0642271901.SGD","BK1544","LU0469268626.HKD","BK1227","HSImain","LU0633140560.USD","LU0143863198.USD","HK0000352291.HKD","LU0791590937.USD","SG9999014674.SGD","IE00BG0RBZ43.SGD","HTCD.SI","LU0650527681.SGD","IE00BZ08YT58.USD","LU0823039010.USD","LU0821914370.USD","LU0084288322.USD","SG9999000459.SGD","LU0348784397.USD","LU0633140727.USD","LU0029874905.USD","IE00BZ08YR35.GBP","LU0175139822.USD","LU0577902611.USD","LU0254981946.USD","LU1226287792.SGD","LU0918141705.HKD","LU2362541513.USD","BK1610","LU1224444064.USD","LU1508157978.USD","MCHmain","IE0009570106.USD","IE00BHRH8C09.USD","LU1267930227.SGD","LU1105468828.SGD","TCHmain","LU0828237510.HKD","HTImain","LU1211504680.USD","LU3227948356.SGD","HK0000288743.USD","81024","LU3063872942.SGD","09115","LU0588546209.SGD","LU0326950275.SGD","LU1196710195.USD","SG9999001051.SGD","TCEHY","03032","LU0396098781.USD","CXSE","03750","LU2177674079.SGD","HK0000151867.HKD","LU0228659784.USD","LU1719994722.HKD","IE0032431581.USD","82828","LU0819121731.USD","03416","LU0828238088.HKD","300750","81810","LU2097828557.USD","ESPO","IE0003851619.USD","LU0588545730.USD","LU0509642566.USD","LU1316542783.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667675725","title":"Chinese Regulator Accepts NDA for Sino Biopharm's Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667675725","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667675725?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:35","pubTimestamp":1789522517,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  said China's Center for Drug Evaluation  has officially accepted the New Drug Application  for its breast cancer treatment, TQB2102 injection, according to a Wednesday bourse filing.The randomized study of 543 patients met its primary endpoint at interim analysis, showing a statistically significant improvement in progression-free survival compared to standard chemotherapy, the filing said.TQB2102 is undergoing multiple clinical trials across distinct solid tumor indications, three of which have been granted Breakthrough Therapy Designations by health regulators in China, the filing noted.The injection has secured two regional licensing partnerships, generating roughly $30 million in upfront and milestone payments forthe company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000165453.HKD","LU1223082196.USD","CDE","01177","BK1589","SGDM","XME","BK1521","BK7050","SIL","CDE.AU","IE00BZ08YR35.GBP","BK1191","LU1223082519.USD","BK1515","LU1223083913.SGD","IE00BZ08YT58.USD","BK4017","IE00BZ08YS42.EUR","GDXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119964450","title":"China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1119964450","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119964450?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:16","pubTimestamp":1789514177,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Ltd (HKG: 01177) has announced that its independently developed Class 1 innovative drug, TQB2102 injection, a HER2 bispecific antibody-drug conjugate (ADC), has received...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","HK0000165453.HKD","01177","IE00BZ08YS42.EUR","BK1589","IPOS","IE00BZ08YR35.GBP","BK1191","IE00BZ08YT58.USD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667620374","title":"Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2667620374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667620374?lang=en_us&edition=fundamental","pubTime":"2026-09-16 07:04","pubTimestamp":1789513445,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570IZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YT58.USD","01177","BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191","IE00BZ08YR35.GBP","BK1521","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667562309","title":"China Traditional Chinese Medicine Says Subsidiaries Enter Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2667562309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667562309?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:10","pubTimestamp":1789485004,"startTime":"0","endTime":"0","summary":"BRIEF-China Traditional Chinese Medicine Says Subsidiaries Enter ContractsSept 15 (Reuters)-China Traditional Chinese Medicine Holdings Co Ltd0570.HK:SUBSIDIARIES ENTER CONTRACTS ON SEPT 15, 2026PHARM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1191","00570","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642410","title":"China Traditional Chinese Medicine - Pharmengin Contracted for Shandong Yifang Renovation Project at Rmb10.6 Mln, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642410?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:29","pubTimestamp":1789475358,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570MU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1606","BK1191","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642142","title":"China Traditional Chinese Medicine Holdings - Subsidiaries Enter Contracts on Sept 15, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642142?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:29","pubTimestamp":1789475358,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00570","BK1191","BK1606","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101920109","title":"ALI HEALTH Awards 7.67 Million Restricted Share Units Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1101920109","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101920109?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:52","pubTimestamp":1789473149,"startTime":"0","endTime":"0","summary":"ALI HEALTH (00241) has announced the grant of a total of 7,672,500 restricted share units to 16 grantees on September 15, 2026, subject to acceptance.The grants were made under the terms of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1615","BK1584","BK1189","BK1571","BK1247","HK0000165453.HKD","BK1617","BK1501","BK1142","BK1502","BK1589","BK1610","00241","BK1591","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644981","title":"CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644981","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644981?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:49","pubTimestamp":1789472968,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said its SYS6010 drug has received Breakthrough Therapy Designation from China's National Medical Products Administration.The designation covers the treatment of recurrent or metastatic non-squamous non-small cell lung cancer with actionable genomic alteration-negative status in patients whose disease has progressed after prior immunotherapy and platinum-based chemotherapy, according to a Tuesday Hong Kong exchange filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1807302812.USD","LU1993786604.SGD","LU1008478684.HKD","LU0072913022.USD","LU1226287792.SGD","LU1226288170.HKD","SG9999004220.SGD","IE00BZ08YT58.USD","01093","LU0315179316.USD","KURE","LU1813983027.USD","IE00BZ08YR35.GBP","IE0008369823.USD","IE00B031HY20.USD","LU2039709279.SGD","LU1328277881.USD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1515","LU1152091754.HKD","LU1152091168.USD","LU0880133367.SGD","BK1521","IE0008368742.USD","LU1960683339.HKD","LU0501845795.SGD","BK1191","LU0067412154.USD","IE00B5MMRT66.SGD","LU1226287875.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287529.USD","LU0314109678.HKD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646466","title":"Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646466","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646466?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:28","pubTimestamp":1789468089,"startTime":"0","endTime":"0","summary":"Sept 15 (Reuters) - CSPC PHARMACEUTICAL <1093.HK>::*SYS6010 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA IN CHINA FOR NSCLC*Further company coverage: 1093.HK* ((Reuters.Briefs@thomsonreuters.com;)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nRSDbrrGqm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","BK1191","LU1813983027.USD","LU1226287529.USD","LU1152091754.HKD","LU1226288253.USD","LU1226287792.SGD","KURE","LU1951186391.HKD","BK1521","LU0140636845.USD","01093","LU0067412154.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","HK0000165453.HKD","LU2039709279.SGD","IE0008369823.USD","LU1226287875.USD","LU0072913022.USD","LU1807302812.USD","LU1960683339.HKD","IE0008368742.USD","LU1152091168.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1993786604.SGD","LU0326950275.SGD","LU1328277881.USD","LU0880133367.SGD","IE00B031HY20.USD","BK1515","IE00BZ08YT58.USD","LU1008478684.HKD","LU0314109678.HKD","LU0315179316.USD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167369366","title":"CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1167369366","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167369366?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:10","pubTimestamp":1789467046,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its innovative drug candidate, SYS 6010, has been included in the Breakthrough Therapy Designation list by China's National Medical Products Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","01093","LU1226288253.USD","LU0326950275.SGD","LU1226288170.HKD","LU1993786604.SGD","LU1226287875.USD","IE00BZ08YT58.USD","LU2039709279.SGD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU1807302812.USD","LU0314109678.HKD","IE0008369823.USD","IE00B031HY20.USD","LU0072913022.USD","LU1813983027.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU1226287792.SGD","LU0501845795.SGD","LU1328277881.USD","LU0315179316.USD","IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","LU1226287529.USD","IE00BZ08YS42.EUR","LU0067412154.USD","SG9999004220.SGD","KURE","LU1960683339.HKD","IE0008368742.USD","LU1951186391.HKD","LU0140636845.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645268","title":"CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645268?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:02","pubTimestamp":1789466529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226288170.HKD","LU1152091168.USD","LU2039709279.SGD","BK1191","IE0008368742.USD","LU0072913022.USD","LU1807302812.USD","BK1515","IE00B543WZ88.USD","IE00B031HY20.USD","LU0067412154.USD","LU1951186391.HKD","LU1993786604.SGD","LU1008478684.HKD","01093","SG9999004220.SGD","LU1152091754.HKD","LU1328277881.USD","IE00BZ08YT58.USD","IE0008369823.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1226287875.USD","LU1960683339.HKD","BK1521","IE00B5MMRT66.SGD","KURE","LU0314109678.HKD","HK0000165453.HKD","LU0880133367.SGD","LU0326950275.SGD","LU0140636845.USD","IE00BZ08YR35.GBP","LU1813983027.USD","LU1226288253.USD","LU0501845795.SGD","LU1226287529.USD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150603956","title":"GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603956","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603956?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:52","pubTimestamp":1789465934,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 15, 2026, the company spent HK$1.2956 million to repurchase 50,000 of its own shares.The share buyback represents the company's ongoing commitment to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","BK1515","02595","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128125870","title":"Fosun Pharma Spends HK$22.07 Million on Share Buyback on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1128125870","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128125870?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:44","pubTimestamp":1789465484,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) made a notable market move on September 15, 2026, as the company announced the repurchase of 1.3 million of its own shares. The transaction,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1515","HELS","BK1593","BK0060","BK0028","02196","BK0183","BK0196","BK0012","BK1191","BK0188","BK0096","600196","BK0187","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610979","title":"CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610979?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slid 1.9% to 8.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.CSPC Pharmaceutical Group Ltd. closed 21% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.0%, SSY Group Ltd. rose 2.1%, and United Laboratories International Holdings Ltd. fell 2.8%.Trading volume totaled 51.4 million shares, compared to the 50-day average of 102.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","SG9999004220.SGD","LU1813983027.USD","LU0067412154.USD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1152091168.USD","LU1226287529.USD","BK1521","IE0008369823.USD","LU2039709279.SGD","HK0000165453.HKD","LU1008478684.HKD","LU1328277881.USD","01093","LU1960683339.HKD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU1152091754.HKD","IE00B031HY20.USD","LU0880133367.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU0140636845.USD","KURE","LU1993786604.SGD","LU0315179316.USD","LU0326950275.SGD","IE0008368742.USD","LU1226288253.USD","LU1226287792.SGD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1226287875.USD","LU0072913022.USD","LU1951186391.HKD","BK1515","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BIB","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2242646821.SGD","BBH","IE00BZ08YR35.GBP","LU0058720904.USD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0109394709.USD","LU1023059063.AUD","BK4585","IE0009355771.USD","BK4566","BK4534","IE00B2B36J28.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0889565916.HKD","LU1061106388.HKD","BK1515","LU1983299246.USD","LU2112291526.USD","TBXU","HK0000165453.HKD","LU0868494617.USD","BK4139","LU1057294990.SGD","01177","IE00BZ08YT58.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK1191","BK1521","IE0002141913.USD","BK4533","PBE","PJP","AMGN","BK4581","LU2242652126.USD","LU1571399168.USD","BK4599","BK4588","LU0320765992.SGD","IBBQ","IBB","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667975610","title":"Alibaba Health Information Technology Stock Slides 2.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667975610","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667975610?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:32","pubTimestamp":1789461120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. slipped 2.5% to 2.93 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 63% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. rose 0.3%.Trading volume totaled 77.2 million shares, compared to the 50-day average of 91.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","MHImain","09115","MCHmain","BK1584","BK1589","513600","82800","BK1591","BK1142","BK1189","03037","BK1247","BK1515","00241","83115","BK1615","07300","HK0000165453.HKD","BK1501","03115","BK1502","02800","02833","03419","HHImain","BK1571","07500","BK1610","BK1617","HSTECH","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","09637","BK4588","BK1191","159938","VXUS","09939","BK1574","BK4585","BK1515","KCAI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":179,"code":"91000000","status":"200"}]}}